[1] 岳远佳,李育,王慧敏,等.近十年中医药研究心肌缺血可视化分析[J].今日药学,2023,33(12):918-921.
[2] 塔娜, 魏成喜. 线粒体自噬在心肌缺血再灌注损伤的研究进展[J]. 系统医学, 2023, 8(24): 186-190.
[3] 黄敏,刘水花,张诗雨,等.血府逐瘀汤治疗冠心病研究进展[J].光明中医,2024,39(4):831-834.
[4] 王阶,姚魁武,邢雁伟,等.冠心病病证结合临床研究与实践[J]. 中医杂志. 2015. 56(24):2089-2092,2097.
[5] 薄颖异,张玥辉,于冰莉.中医药防治冠心病研究进展[J].内蒙古中医药,2024,43(3):161-162.
[6] 傅春燕,刘永辉,曾立,等.血府逐瘀汤化学成分、药理作用及临床应用研究进展[J].亚太传统医药,2024,20(5):232-237.
[7] 吴浩南,李盈盈,刘思鸿,等.血府逐瘀汤治疗冠心病可视化分析[J].中国中医基础医学杂志,2023,29(2):250.
[8] Zhou R, Yazdi AS, Menu P, et al.A role for mitochondria in NLRP3 inflammasome activation[J]. Nature,2011,469(7329) : 221–225
[9] Cruz CM, Rinna A, Forman HJ, et al.ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages[J]. J Biol Chem,2007,282(5) : 2871–2879.
[10] He Q,Li Z,Meng C,et al.Parkin – Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia – Reperfusion Injury in Rats[J]. Cells,2019,8(8) : 897.
[11] Kim MJ, Yoon JH, Ryu JH.Mitophagy: a balance regulator of NLRP3 inflammasome activation[J]. BMB Rep,2016,49(10) : 529-535.
[12] 王姝雯,白旭峰,刘亚丽,等.线粒体自噬与NLRP3炎症小体调控通路及中医药干预的关系研究进展[J].河北医药,2024,46(4):595-600.
[13] Green DR, Van Houten B.SnapShot: Mitochondrial quality control[J]. Cell,2011,147(4) : 950.
[14] 周俊,胡犇,戢力维,等. 中药对线粒体自噬影响的研究进展[J]. 中国医药导报,2021,18(22) : 50–54.
[15] Yu LP, Shi TT, Li YQ, et al.The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models[J]. Curr Pharm Des, 2022,28(6) : 488–496.
[16] Yang L,Tao Y,Luo L,et al.Dengzhan Xixin injection derived from a traditional Chinese herb Erigeron breviscapus ameliorates cerebral ischemia/reperfusion injury in rats via modulation of mitophagy and mitochondrial apoptosis[J]. J Ethnopharmacol, 2022,288: 114988.
[17] Tao Y W,Yang L,Chen S Y,et al.Pivotal regulatory roles of traditional Chinese medicine in ischemic stroke via inhibition of NLRP3 inflammasome[J]. J Ethnopharmacol,2022,294: 115316. |
